Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic

Y Tian1, Y B Deng, Y J Huang

  • 1Department of Pathophysiology, Zhongshan Medical College, Sun Yat-sen University, Guangzhou, PR China.

Immunological Investigations
|January 25, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

[Nomogram predictive model for the risk of critical pneumonia in children infected with respiratory syncytial virus].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2026
Same author

[A case of severe RSV pneumonia in children and literature review].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025
Same author

[Clinical characteristics of severe human metapneumovirus infection in children and analysis of risk factors for critical illness].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2025
Same author

[Analysis of risk factors for delirium in elderly patients with head and neck cancer after free flap reconstruction surgery].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2025
Same author

[A case report of pyriform sinus fistula secondary to descending necrotizing mediastinitis and pyothorax].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2024
Same journal

Immune Reconstitution After Hematopoietic Stem Cell Transplantation: Cellular Dynamics, Clinical Determinants, and Emerging Therapeutic Strategies.

Immunological investigations·2026
Same journal

Riboflavin Modulates Complement Activation, Immune Cell Viability and Activation, and Neutrophil Microbicidal Functions <i>in Vitro</i>.

Immunological investigations·2026
Same journal

Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies.

Immunological investigations·2026
Same journal

Nanoantibodies: A Review of Diagnostic and Therapeutic Applications in Respiratory Diseases.

Immunological investigations·2026
Same journal

TRIM31: A Novel Guardian Against Periodontal Inflammation via Modulation of NLRP3 Inflammasome and Macrophage Polarization.

Immunological investigations·2026
Same journal

LincRNA-Cox2 in Inflammation: Regulatory Networks, Experimental Insights, and Future Directions.

Immunological investigations·2026
See all related articles

Mesenchymal stem cells (MSC) prevent lethal graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). MSCs restore T cell balance, reducing GVHD severity and improving outcomes in transplant patients.

Area of Science:

  • Immunology
  • Hematology
  • Stem Cell Biology

Background:

  • Graft-versus-host disease (GVHD) is a life-threatening complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT).
  • Mesenchymal stem cells (MSCs) possess immunomodulatory properties and have shown potential in mitigating GVHD.
  • Understanding the precise mechanisms by which MSCs exert their protective effects in GVHD is crucial for optimizing therapeutic strategies.

Purpose of the Study:

  • To investigate the mechanisms underlying the protective effects of bone marrow-derived mesenchymal stem cells (BM-MSCs) against acute GVHD in a rat model.
  • To evaluate the impact of MSC co-transplantation on T cell differentiation and subset populations following allo-HSCT.

Main Methods:

  • An acute GVHD rat model was established using allogeneic hematopoietic stem cells (HSCs) with donor T cells, with or without co-transplantation of donor-derived MSCs.

Related Experiment Videos

  • GVHD severity was assessed and compared between groups.
  • Flow cytometry and RT-PCR analyses were employed to evaluate the in vivo differentiation of CD4+, CD8+, Th1/Th2, and CD4+CD25+ T cells in spleen lymphocytes and thymocytes.

    • Main Results:

    • Co-transplantation with MSCs significantly inhibited lethal GVHD following allo-HSCT.
    • MSC treatment led to a decrease in CD8+ and CD4+ T cells and a reduced Th1/Th2 T cell ratio.
    • A notable increase in the proportion of CD4+CD25+ T cells was observed in spleen lymphocytes and thymocytes in MSC-treated rats compared to controls.

    Conclusions:

    • Bone marrow-derived MSCs effectively prevent lethal GVHD after allo-HSCT.
    • MSC-mediated protection is associated with the restoration of T cell subset homeostasis in vivo.
    • These findings highlight the therapeutic potential of MSCs in managing GVHD post-transplantation.